Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoko Shinohara

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
ACS Omega|April 21, 2020
Epigenetic TET-Catalyzed Oxidative Products of 5-Methylcytosine Impede Z-DNA Formation of CG DecamersVorasit Vongsutilers, Yoko Shinohara, Gota Kawai
Scientific Reports|May 26, 2021
Influence of the 5'-terminal sequences on the 5'-UTR structure of HIV-1 genomic RNACamille Michiko Obayashi, Yoko Shinohara, Takao Masuda, et al.
Nucleosides, Nucleotides & Nucleic Acids|September 7, 2018
5-Methylcytosine containing CG decamer as Z-DNA embedded sequence for a potential Z-DNA binding protein probeVorasit Vongsutilers, Kulwadee Sawaspaiboontawee, Bodin Tuesuwan, et al.
Journal of Biochemistry|April 28, 2025
NMR analysis of interaction between RNA structure elements and small moleculesMegumi Tomemori, Rika Ichijo, Yoko Shinohara, et al.
Journal of Biochemistry|June 23, 2026
NMR analysis of interaction between RNA structure elements and small molecules: evaluation of RNA libraries and confirmation by two more moleculesRika Ichijo, Yoko Shinohara, Kaori Hatta, et al.
Internal Medicine (Tokyo, Japan)|May 20, 2015
Neurological Symptoms of Sarcoidosis-induced Small Fiber Neuropathy Effectively Relieved with High-dose Steroid Pulse TherapyHiroaki Saito, Tetsuo Yamaguchi, Yuta Adachi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 23, 2009
[S-1 activity in non-small cell lung cancer in clinical practice]Masaharu Inagaki, Takuya Onuki, Kesato Iguchi, et al.
Molecular and Clinical Oncology|March 22, 2016
Efficacy of first-line erlotinib in non-small cell lung cancer patients undergoing dose reduction and those with a low body surface area: A population-based observational study by the Ibaraki Thoracic Integrative (POSITIVE) Research GroupMasaharu Inagaki, Yoko Shinohara, Takayuki Kaburagi, et al.
Molecular and Clinical Oncology|June 11, 2016
S-1-containing chemotherapy for patients with non-small-cell lung cancer: A population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research groupMasaharu Inagaki, Yoko Shinohara, Takayuki Kaburagi, et al.
Medical Oncology (Northwood, London, England)|November 1, 2008
A population-based study of gefitinib in patients with non-small cell lung cancerKenji Hayashibara, Hiroaki Satoh, Yoko Shinohara, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
ACS Omega|April 21, 2020
Epigenetic TET-Catalyzed Oxidative Products of 5-Methylcytosine Impede Z-DNA Formation of CG DecamersVorasit Vongsutilers, Yoko Shinohara, Gota Kawai
Scientific Reports|May 26, 2021
Influence of the 5'-terminal sequences on the 5'-UTR structure of HIV-1 genomic RNACamille Michiko Obayashi, Yoko Shinohara, Takao Masuda, et al.
Nucleosides, Nucleotides & Nucleic Acids|September 7, 2018
5-Methylcytosine containing CG decamer as Z-DNA embedded sequence for a potential Z-DNA binding protein probeVorasit Vongsutilers, Kulwadee Sawaspaiboontawee, Bodin Tuesuwan, et al.
Journal of Biochemistry|April 28, 2025
NMR analysis of interaction between RNA structure elements and small moleculesMegumi Tomemori, Rika Ichijo, Yoko Shinohara, et al.
Journal of Biochemistry|June 23, 2026
NMR analysis of interaction between RNA structure elements and small molecules: evaluation of RNA libraries and confirmation by two more moleculesRika Ichijo, Yoko Shinohara, Kaori Hatta, et al.
Internal Medicine (Tokyo, Japan)|May 20, 2015
Neurological Symptoms of Sarcoidosis-induced Small Fiber Neuropathy Effectively Relieved with High-dose Steroid Pulse TherapyHiroaki Saito, Tetsuo Yamaguchi, Yuta Adachi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 23, 2009
[S-1 activity in non-small cell lung cancer in clinical practice]Masaharu Inagaki, Takuya Onuki, Kesato Iguchi, et al.
Molecular and Clinical Oncology|March 22, 2016
Efficacy of first-line erlotinib in non-small cell lung cancer patients undergoing dose reduction and those with a low body surface area: A population-based observational study by the Ibaraki Thoracic Integrative (POSITIVE) Research GroupMasaharu Inagaki, Yoko Shinohara, Takayuki Kaburagi, et al.
Molecular and Clinical Oncology|June 11, 2016
S-1-containing chemotherapy for patients with non-small-cell lung cancer: A population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research groupMasaharu Inagaki, Yoko Shinohara, Takayuki Kaburagi, et al.
Medical Oncology (Northwood, London, England)|November 1, 2008
A population-based study of gefitinib in patients with non-small cell lung cancerKenji Hayashibara, Hiroaki Satoh, Yoko Shinohara, et al.
Pageof 2